Logo image of NXU

NXU INC (NXU) Stock Fundamental Analysis

NASDAQ:NXU - Nasdaq - US62956D2045 - Common Stock - Currency: USD

0.3064  -0.02 (-7.15%)

After market: 0.2981 -0.01 (-2.71%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NXU. NXU was compared to 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of NXU have multiple concerns. NXU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NXU had negative earnings in the past year.
In the past year NXU has reported a negative cash flow from operations.
In the past 5 years NXU always reported negative net income.
NXU had a negative operating cash flow in each of the past 5 years.
NXU Yearly Net Income VS EBIT VS OCF VS FCFNXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

NXU's Return On Assets of -94.04% is on the low side compared to the rest of the industry. NXU is outperformed by 97.44% of its industry peers.
With a Return On Equity value of -154.17%, NXU is not doing good in the industry: 81.20% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -94.04%
ROE -154.17%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXU Yearly ROA, ROE, ROICNXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K

1.3 Margins

NXU has a Gross Margin of 78.03%. This is amongst the best in the industry. NXU outperforms 98.29% of its industry peers.
The Profit Margin and Operating Margin are not available for NXU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXU Yearly Profit, Operating, Gross MarginsNXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 -2K -4K -6K -8K

More info and screens

3

2. Health

2.1 Basic Checks

NXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
NXU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NXU Yearly Shares OutstandingNXU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M
NXU Yearly Total Debt VS Total AssetsNXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -19.84, we must say that NXU is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NXU (-19.84) is worse than 95.73% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NXU is not too dependend on debt financing.
The Debt to Equity ratio of NXU (0.00) is better than 75.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.84
ROIC/WACCN/A
WACC7.44%
NXU Yearly LT Debt VS Equity VS FCFNXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

2.3 Liquidity

A Current Ratio of 1.50 indicates that NXU should not have too much problems paying its short term obligations.
NXU has a Current ratio (1.50) which is in line with its industry peers.
NXU has a Quick Ratio of 1.50. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NXU (1.50) is better than 83.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
NXU Yearly Current Assets VS Current LiabilitesNXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.16% over the past year.
Looking at the last year, NXU shows a very strong growth in Revenue. The Revenue has grown by 230.00%.
EPS 1Y (TTM)82.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.73%
Revenue 1Y (TTM)230%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-94.87%

3.2 Future

The Earnings Per Share is expected to grow by 41.37% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -41.42% on average over the next years. This is quite bad
EPS Next Y99.33%
EPS Next 2Y41.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NXU Yearly Revenue VS EstimatesNXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 100K 200K 300K 400K
NXU Yearly EPS VS EstimatesNXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NXU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXU Price Earnings VS Forward Price EarningsNXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXU Per share dataNXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80

4.3 Compensation for Growth

NXU's earnings are expected to grow with 41.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.37%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NXU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NXU INC

NASDAQ:NXU (2/21/2025, 5:07:53 PM)

After market: 0.2981 -0.01 (-2.71%)

0.3064

-0.02 (-7.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners0.93%
Inst Owner Change102.77%
Ins Owners2.99%
Ins Owner Change0.05%
Market Cap5.18M
Analysts45
Price TargetN/A
Short Float %20.88%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.87%
Min EPS beat(2)-38.61%
Max EPS beat(2)-11.13%
EPS beat(4)1
Avg EPS beat(4)-287.55%
Min EPS beat(4)-1104.62%
Max EPS beat(4)4.15%
EPS beat(8)3
Avg EPS beat(8)-143.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)31.03%
EPS NQ rev (3m)60%
EPS NY rev (1m)5.5%
EPS NY rev (3m)5.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.08
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-93.13
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS0.02
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -94.04%
ROE -154.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.03%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 255.78%
Cap/Sales 581.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -19.84
F-Score5
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)659.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.73%
EPS Next Y99.33%
EPS Next 2Y41.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)230%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-94.87%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.84%
OCF growth 3YN/A
OCF growth 5YN/A